EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study

Peng, P; Gong, JJ; Zhang, YJ; Zhou, SC; Li, YC; Han, G; Meng, R; Chen, YS; Yang, M; Shen, Q; Chu, Q; Xia, S; Zhang, P; Zhang, L; Chen, Y; Zhang, L

Chen, Y; Zhang, L (通讯作者)，Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan 430030, Hubei, Peoples R China.

RADIOTHERAPY AND ONCOLOGY, 2023; 184 ():

Abstract

Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have a significant therapeutic effect in the treatment of advanced......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索